EUVIMEDEUVIMED entdecken
Crossref

PTCH1-Related Gorlin Syndrome: Expanding the Clinical and Molecular Spectrum in a Cohort of 11 Patients

Ayşe Burcu Doğan Arı iD, Büşra Çavdarlı, Gülay Güleç Ceylan, Selma Çakmakcı, Esra Kılıç

Klinische Pädiatrie · 16.07.2026 · 238 (06) · 357-366

DOI: 10.1055/a-2896-4106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 16.07.2026. Verfasst von Ayşe Burcu Doğan Arı und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Health Sciences, Ankara Bilkent City Children's Hospital, Department of Pediatric Genetics, Ankara, Turkey, Çankaya.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gorlin syndrome (GS, MIM #109400) is a cancer predisposition syndrome characterized by macrocephaly, odontogenic keratocysts, calcification of the falx cerebri, basal cell carcinoma, and medulloblastoma. It is caused by pathogenic variants in the PTCH1 and SUFU genes. Patients and Methods We evaluated the clinical and molecular features of 11 patients with GS using single-gene testing, multigene panel analysis, and clinical exome sequencing.

Results

All patients exhibited characteristic craniofacial features. Macrocephaly was observed in 10 patients (90.9%) and odontogenic keratocysts in nine patients (81.8%). Palmar pits and falx cerebri calcification were observed in eight patients (72.7%). Basal cell carcinoma occurred in four patients (36.3%), and medulloblastoma in two (18.2%). GS was clinically suspected based on the observed clinical and radiological findings in all patients. Seven distinct heterozygous pathogenic PTCH1 variants were identified, four of which were novel. One patient had a dual diagnosis of L-2-hydroxyglutaric aciduria.

Discussion

These findings underscore the marked phenotypic variability of PTCH1-related GS. Due to age-dependent clinical manifestations, patients require regular long-term surveillance and comprehensive clinical assessment.

Conclusion

Molecular confirmation of the diagnosis is important for the provision of genetic counselling, consideration of preimplantation genetic diagnosis, and appropriate patient follow-up and treatment planning.

Autor:innen und Institutionen

  • University of Health Sciences, Ankara Bilkent City Children's Hospital, Department of Pediatric Genetics, Ankara, Turkey, Çankaya.
  • Ankara Bilkent City Hospital, Department of Medical Genetics, Ankara, Turkey, Çankaya.
  • Ankara Yildirim Beyazit University, Department of Medical Genetics, Turkey, Ankara.
  • University of Health Sciences, Ankara Bilkent City Children's Hospital, Department of Pediatrics Hematology-Oncology, Ankara, Turkey, Çankaya.

ORCID-Profile: Ayşe Burcu Doğan Arı

Zitieren

APA

Doğan Arı, A. B., Çavdarlı, B., Güleç Ceylan, G., Çakmakcı, S., & Kılıç, E. (2026). PTCH1-Related Gorlin Syndrome: Expanding the Clinical and Molecular Spectrum in a Cohort of 11 Patients. Klinische Pädiatrie, 238(06), 357-366. https://doi.org/10.1055/a-2896-4106

Vancouver

Doğan Arı AB, Çavdarlı B, Güleç Ceylan G, Çakmakcı S, Kılıç E. PTCH1-Related Gorlin Syndrome: Expanding the Clinical and Molecular Spectrum in a Cohort of 11 Patients. Klinische Pädiatrie. 2026;238(06):357-366. doi:10.1055/a-2896-4106

BibTeX
@article{DoanAr2026,
  author = {Doğan Arı, Ayşe Burcu and Çavdarlı, Büşra and Güleç Ceylan, Gülay and Çakmakcı, Selma and Kılıç, Esra},
  title = {PTCH1-Related Gorlin Syndrome: Expanding the Clinical and Molecular Spectrum in a Cohort of 11 Patients},
  journal = {Klinische Pädiatrie},
  year = {2026},
  volume = {238},
  number = {06},
  pages = {357--366},
  doi = {10.1055/a-2896-4106}
}
Kostenlos starten →